XENT News and Press, Intersect ENT Inc. From 11/19/19

Intersect ENT, Inc. (NASDAQ: XENT ) today announced that management will participate in the 31 st Annual Piper Jaffray Healthcare Conference on December 4 at the Lotte New York Palace Hotel in New York City, and will present in a session at 4:30 pm ET. A replay of the session will be av...

Image source: The Motley Fool. Intersect ENT   (NASDAQ: XENT) Q3 2019 Earnings Call Nov 01, 2019 , 8:00 a.m. ET Operator Continue reading

Intersect ENT, Inc. (XENT) Q3 2019 Earnings Conference Call November 01, 2019 8:00 AM ET Company Participants Jeri Hilleman - Chief Financial Officer Tom West - President & Chief Executive Officer Conference Call Participants Robbie Marcus - JPMorgan Richard Newitter - ...

Gainers:  Rexahn Pharmaceuticals (NASDAQ: REXN ) +45% . California Resources Corporation (NYSE: CRC ) +40% . BeiGene (NASDAQ: BGNE ) +34% . El Pollo Loco Holdings (NASDAQ: LOCO ) +28% . Acorda Therapeutics (NASDAQ: ACOR ) +26% . American Axle & Manufacturing Holdings (NYSE: A...

Intersect ENT (NASDAQ: XENT ): Q3 GAAP EPS of -$0.41 misses by $0.03 . More news on: Intersect ENT, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today reported financial results for the third quarter ended September 30, 2019. Total revenue was $24.1 million for the third quarter of 2019 compared to $24.7 m...

ABBV , ABR , AIG , AMAG , ASIX , AXL , BABA , BAH , BGG , CBOE , CCJ , CL , CVX , D , FND , FTS , GSHD , HAE , HE , HMSY , HRC , IBP , IMGN , IMO , ITT , LNG , LYB , MD , MGI , MGLN , MOG.A , NWL , OPI , PBA , PNM , POR , ROLL , RUTH , SRE , STX , TP...

Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that it will release third quarter financial results on November 1, 2019. The company expects to issue the release at approximately 7:30 a.m. ET and ...

Gainers:  Akcea Therapeutics (NASDAQ: AKCA ) +29% . Liquid Media Group (NASDAQ: YVR ) +24% . AgeX Therapeutics (NYSEMKT: AGE ) +20% . Sutro Biopharma (NASDAQ: STRO ) +19% . Livongo Health (NASDAQ: LVGO ) +15% . Motus GI Holdings (NASDAQ: MOTS ) +12% . Teekay Tankers (NYSE: TNK )...

Intersect ENT (NASDAQ: XENT ) slumps  26%  premarket on light volume in reaction to unsuccessful results from the randomized ASCEND study evaluating its drug-coated sinus balloon for dilating the frontal sinus ostium to reduce post-balloon dilation edema via the localized deliver...